Iveric Bio announces FDA approval for IZERVAY™️️
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details
Modality Solutions new white paper provides a new approach to transport simulation for drug products. The goal of the drug formulation simulation study is to concurrently expose drug product to all five environmental hazards – temperature, shock, vibration, humidity, and pressure – as they occur during real-world distribution.
The white paper examines the effectiveness of simulated transport studies. It uses a holistic methodology to testing the multiple hazards in cold chain transport. In doing so, the industry best practices of the following areas are explained:
• Hot and cold exposures to a single shipment
• Non-accelerated vibration
• Exposure to multiple pressures
• Parcel-based transport simulation testing
Regulatory expectations are driving leading companies to incorporate simulated transport testing into both their development and stability programs. Learn how Modality Solutions’ Advantage Transport Simulation Laboratory™ enables the study of transport stresses on early-stage drug formulations during the development process and verification of the robustness of the commercial drug product formulation.
Click here to view the Drug Product Formulation Testing White Paper press release.
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read DetailsCongratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic...
read DetailsCongratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset...
read Details